Blockchain Registration Transaction Record
CNS Pharmaceuticals to Showcase Innovative Cancer Treatments at Webull Webinar
CNS Pharmaceuticals to present at Webull Biotech/MedTech webinar, showcasing TPI 287 for CNS cancer treatment. A breakthrough in biopharma innovation.

This news is crucial for investors, healthcare professionals, and patients alike, as it highlights the ongoing advancements in the treatment of brain and central nervous system cancers. CNS Pharmaceuticals' work, particularly with TPI 287, represents a beacon of hope for those affected by these challenging conditions. The company's participation in the Webull webinar series not only underscores the potential of their research but also offers a platform for broader awareness and investment in life-saving treatments.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xfb79feb71e7fda3a024cead24a32309dff55fc2dd96d9cfe37f9d4a4352b93d2 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | smogbs2C-58966bd5f05caf02ef9233bcfa0bf1a2 |